title: [Hemolytic uremic syndrome--a serious complication of mitomycin treatment].
authors.affiliation: TYKS:n sisätautien klinikka, Turku.
authors.forename: O
authors.initials: O
authors.lastname: Arola
authors.forename: H
authors.initials: H
authors.lastname: Aho
authors.forename: M
authors.initials: M
authors.lastname: Asola
authors.forename: M
authors.initials: M
authors.lastname: Kauppila
authors.forename: V
authors.initials: V
authors.lastname: Nikkanen
authors.forename: L M
authors.initials: LM
authors.lastname: Voipio-Pulkki
mesh_terms: D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects*; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects; D004347:Drug Interactions; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000139:chemically induced*; D006801:Humans; D008875:Middle Aged; D016685:Mitomycin / Q000009:adverse effects*; D013629:Tamoxifen / Q000009:adverse effects
chemical_list: D000903:Antibiotics, Antineoplastic; D018906:Antineoplastic Agents, Alkylating; D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen; D016685:Mitomycin